WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Stock

$218.57-1.40 (-0.64%)
Updated May 17, 2024
RMD Price
$218.57
Fair Value Price
N/A
Market Cap
$32.11B
52 Week Low
$132.24
52 Week High
$229.97
P/E
33.52x
P/B
6.94x
P/S
6.35x
PEG
2.51x
Dividend Yield
0.88%
Revenue
$4.58B
Earnings
$958.38M
Gross Margin
55.8%
Operating Margin
27.02%
Profit Margin
20.9%
Debt to Equity
0.47
Operating Cash Flow
$1B
Beta
0.95
Next Earnings
N/A
Ex-Dividend
May 8, 2024
Next Dividend
Jun 13, 2024

RMD Overview

ResMed Inc. manufactures medical equipment for the diagnosis, treatment and management of sleep-disordered breathing, sleep apnea, and chronic obstructive pulmonary disease. Offerings include continuous positive airway pressure devices, auto-bilevel devices, variable positive airway pressure devices, automatic positive airway pressure devices, humidifiers, ventilation products, masks, headgear, and data/patient management products. The comany serves sleep clinics, home healthcare dealers, and third party payers. ResMed was founded in 1989 and is headquartered in San Diego, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RMD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RMD ($218.57) is trading above its intrinsic value of $66.28, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RMD is poor value based on its earnings relative to its share price (33.52x), compared to the US market average (30.97x)
P/E vs Market Valuation
RMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more RMD due diligence checks available for Premium users.

Be the first to know about important RMD news, forecast changes, insider trades & much more!

RMD News

Valuation

RMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
33.52x
Industry
59.83x
Market
30.97x
RMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

RMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.94x
Industry
3.64x
RMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RMD price to earnings growth (PEG)

For valuing profitable companies with growth potential
RMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

RMD's financial health

Profit margin

Revenue
$1.2B
Net Income
$300.5M
Profit Margin
25.1%
RMD's Earnings (EBIT) of $1.24B... subscribe to Premium to read more.
Interest Coverage Financials
RMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.8B
Liabilities
$2.2B
Debt to equity
0.47
RMD's short-term assets ($2.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RMD's short-term assets ($2.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$402.0M
Investing
-$33.2M
Financing
-$335.9M
RMD's operating cash flow ($1.20B)... subscribe to Premium to read more.
Debt Coverage Financials

RMD vs Medical Stocks

TickerMarket Cap1d %P/EP/B
RMD$32.11B-0.64%33.52x6.94x
WST$25.91B+0.43%46.37x9.66x
ALC$43.92B-0.26%41.90x2.11x
COO$19.34B-0.60%66.42x2.51x
BAX$17.96B+0.23%6.74x2.20x

Resmed Stock FAQ

What is Resmed's quote symbol?

(NYSE: RMD) Resmed trades on the NYSE under the ticker symbol RMD. Resmed stock quotes can also be displayed as NYSE: RMD.

If you're new to stock investing, here's how to buy Resmed stock.

What is the 52 week high and low for Resmed (NYSE: RMD)?

(NYSE: RMD) Resmed's 52-week high was $229.97, and its 52-week low was $132.24. It is currently -4.96% from its 52-week high and 65.28% from its 52-week low.

How much is Resmed stock worth today?

(NYSE: RMD) Resmed currently has 146,907,207 outstanding shares. With Resmed stock trading at $218.57 per share, the total value of Resmed stock (market capitalization) is $32.11B.

Resmed stock was originally listed at a price of $1.76 in Dec 31, 1997. If you had invested in Resmed stock at $1.76, your return over the last 26 years would have been 12,332.88%, for an annualized return of 20.38% (not including any dividends or dividend reinvestments).

How much is Resmed's stock price per share?

(NYSE: RMD) Resmed stock price per share is $218.57 today (as of May 17, 2024).

What is Resmed's Market Cap?

(NYSE: RMD) Resmed's market cap is $32.11B, as of May 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Resmed's market cap is calculated by multiplying RMD's current stock price of $218.57 by RMD's total outstanding shares of 146,907,207.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.